Business of Cannabis…
Header Image: FSA CEO Emily Miles
The UK’s CBD industry will have to wait for at least another year before any products are fully authorised by regulators.
Earlier this month, the Food Standards Agency (FSA) responded to a letter submitted by the Association for the Cannabinoid Industry (ACI), raising concerns over continued delays to the process and the ongoing impact this was having on the UK’s CBD industry.
According to The Grocer, the FSA’s CEO Emily Miles, stuck with the organisation’s long-standing response to accusations of delays, pointing out that in many cases, the ‘data provided by applicants has been poor or its relevance to the application is unclear’.
Furthermore, she said that the unique process the FSA has taken regarding CBD approvals had ‘created greater resource demands’ on the FSA.
In light of this, following an announcement from earlier this month that the first two ‘positive safety assessments’ in the CBD Novel Foods process had now been issued to Channelle McCoy and Cannaray, Ms. Miles said she was hopeful that the first products would receive full authorisation in the next 12 months.
However, she stipulated that this depended on the Home Office confirming the ‘legal status of CBD products containing trace amounts of THC’.
As we begin 2024, the ACI is keen to expedite regulation of the #cbd sector, ensuring consumer safety, reassuring regulators and providing businesses with the certainty they need to plan and grow.
Read how we can do it here:https://t.co/BiE5RaLUSv
— ACI (@ACIndustry) January 9, 2024
